L'Oreal says weight loss drugs are impacting beauty and skincare sales
0 / 13
English
中文
The use of weight loss drugs, known as GLP-1s, has increased in popularity in recent years Beauty giant L'Oreal says the rise of weight loss drugs has affected beauty and skincare sales, as it designs products to specifically target some side-effects of rapid weight loss.
（暂无翻译）
The company's head Nicolas Hieronimus said the beauty market was proving resilient in a challenging global context and that the use of GLP-1s was "a very important phenomenon for us".
（暂无翻译）
He told an investor call that the rise in their use was "having an impact on beauty consumption and skin care consumption in particular".
（暂无翻译）
L'Oreal, which owns other popular brands including Maybelline and La Roche-Posay, announced on Thursday that sales in the three months to September rose by 7.7%, above analyst expectations.
（暂无翻译）
The use of GLP-1s has boomed in popularity in recent years, after drugs developed to treat diabetes such as Ozempic, Wegovy and Mounjaro were found to also lead to significant weight loss because they supress the appetite.
（暂无翻译）
While it is not caused by GLP-1 drugs directly, rapid weight loss can, for some people, come with a side-effect of loose skin - including around the face.
（暂无翻译）
Hieronimus said L'Oreal's brands SkinCeuticals and Kiehl's have products "that have been designed to work alongside and complement GLP-1 and its side-effects on skin sagging" and other effects related to rapid weight loss.
（暂无翻译）
L'Oreal has also moved further into the clinical aesthetic space, increasing its stake in dermatology firm Galderma to 20% last December.
（暂无翻译）
Both companies have been testing products on GLP-1 users worried about loose skin in separate clinical trials, according to Reuters.
（暂无翻译）
Galderma owns popular aesthetic products including Sculptra, an injectable aimed at stimulating collagen production, and Restylane, which is an injectable dermal filler.
（暂无翻译）
Last year the aesthetic firm released a report into the rise of GLP-1 use and related concerns about changes in facial appearance.
（暂无翻译）
Its own survey of weight loss medication users found the vast majority had noticed changes to their facial appearance after using those drugs.
（暂无翻译）
How weight loss jabs have changed the battle with obesity
（暂无翻译）
仅供学习使用，如有侵权请联系删除 · 查看原文